BioMarin Loses Hormone Patent In Europe
A European appeals panel has stripped U.S. biotech firm BioMarin of its patent for a hormone that helps regulate heart and bone health, following a challenge from a Danish rival....To view the full article, register now.
Already a subscriber? Click here to view full article